All Articles by Author:
Noshin Noorjahan
Cell Therapy News
High Endothelial Venules in Cancer: Regulation, Function, and Therapeutic Implication
[Cancer Cell] Scientists provide current insight into the commonalities and discrepancies of high endothelial venule (HEV) formation and regulation in lymph nodes and tumors, and discuss the specific function and significance of tumor-HEVs in eliciting, predicting, and aiding anti-tumoral immunity.
Endothelial Cell News
Blood Vessel Organoids for Development and Disease
[Circulation Research] The authors discuss novel and alternative approaches to blood vessel engineering and explore the cellular identity of engineered blood vessels in comparison to in vivo vasculature.
Cell Therapy News
Transcription Factors Regulating Vasculogenesis and Angiogenesis
[Developmental Dynamics] Investigators discuss the cohort of transcription factors known to be involved in directing gene expression during different stages of mammalian vasculogenesis and angiogenesis with a primary focus on development.
Intestinal Cell News
Targeting ACE2-BRD4 Crosstalk in Colorectal Cancer and the Deregulation of DNA Repair and Apoptosis
[npj Precision Oncology] Scientists reported that knockdown, forced overexpression, and pharmacologic inhibition of angiotensin I-converting enzyme 2 (ACE2) in human colon cancer cells targeted (ACE2)-BRD4 crosstalk to mediate marked changes in DNA damage/repair and apoptosis.
Intestinal Cell News
METTL14-Dependent Maturation of Pri-miR-17 Regulates Mitochondrial Homeostasis and Induces Chemoresistance in Colorectal Cancer
[Cell Death & Disease] Investigators found that overexpression of miR-17-5p led to less apoptosis and lower drug sensitivity in vitro and in vivo under the 5-fluorouracil (5-FU) treatment, which indicated miR-17-5p led to 5-FU chemotherapy resistance.
Intestinal Cell News
Ibrutinib Facilitates the Sensitivity of Colorectal Cancer Cells to Ferroptosis through BTK/NRF2 Pathway
[Cell Death & Disease] Ibrutinib sensitized colorectal cancer (CRC) to ferroptosis inducers, suggested by reduced CRC cell viability, proliferation, and decreased antioxidant protein levels in CRC cells after combination treatment of Ibrutinib and RSL3 or Ibrutinib and Erastin both in vivo and in vitro.
Popular
FDA Approves Cabozantinib for Adults and Pediatric Patients 12 Years of Age and Older with pNET and epNET
[FDA] The FDA approved cabozantinib for adult and pediatric patients 12 years of age and older with previously treated, unresectable, locally advanced or metastatic, well-differentiated pancreatic neuroendocrine tumors (pNET) and well-differentiated extra-pancreatic neuroendocrine tumors (epNET).
Spermidine Restricts Neonatal Inflammation via Metabolic Shaping of Polymorphonuclear Myeloid-Derived Suppressor Cells
[Journal of Clinical Investigation] Scientists reported that plasma spermidine was correlated with the maturity of human newborns and reduced risk of inflammation. Administration of spermidine led to the remission of neonatal inflammation in mice.
Enhancing Anti-CD3 mAb-Mediated Diabetes Remission in Autoimmune Diabetes through Regulation of Dynamin-Related Protein 1(Drp1)-mediated Mitochondrial Dynamics in Exhausted CD8+T-Cell Subpopulations
[BMC Medicine] The phenotypic and metabolic properties of two subsets of exhausted CD8+ T cells were analyzed in both humans and NOD mice. T-cell receptor (TCR) diversity and Bulk RNA sequencing provided insights into the transcriptomic profiles and TCR reactivity of these cells.